Anda di halaman 1dari 30

BIOTECHNOLOGY Unprecedented Growth Opportunity

March, 2005

Biotechnology

India - An Overview
Market and Growth Potential Players Opportunities Why India? Contact in India
March, 2005

India - An Introduction
Population States/UTs Geographical Area Languages recognised Business language Per Capita Income** GDP**
**(at factor cost & at current prices) 1USD=43.54 INR (as on July 4, 2005)
March, 2005

Over 1 bn 35

3.3 mn sq kms
22

English
US$ 534

US$ 650 bn
Source:CSO Statistics

India - Fast pace Growth


Largest democracy 4th largest economy by PPP index 6th largest energy consumer ForEx reserves skyrocket from US$ 42 bn (2001) to

US$ 133 bn (February, 2005)


GDP growth to continue between 6-8% 3rd largest economy by 2050: Goldman Sachs Leading in IT & BPO Oil & Gas and Biotechnology sunrise industries
March, 2005

India - Leading the world


Hero Honda - largest manufacturer of motorcycles Moser Baer - among the top three media manufacturers

in the world
Pharmaceutical Industry - 4th largest in world Walmart, GAP, Hilfiger sources more than USD 1bn worth apparel from India 100 Fortune 500 have set R&D facilities in India

including GE, Delphi, Eli Lilly, HP, Heinz and Daimler


Chrysler
March, 2005

Biotechnology

India - An Overview
Market and Growth Potential Players Opportunities Why India? Contact in India
March, 2005

Biotech Market - Dynamic and growing

Size (2004-05) Largest segment Revenue from exports (2003-04)

US$ 1090.5 mn

Biopharma 56%

Total investment (2003-04) Rate of growth over 202-2003

US$ 137 million 26%

March, 2005

Biopharma leads the way


Composition of Indian Biotech Sector (2004-05)
Bio Agri 6.95% Bio Industrial 6.74%

Bio-IT 2.09 %

Bio Services 8.95%

Bio Pharma 75.24 %


Source:Biospectrum-ABLE Survey

March, 2005

Market - A consistent uptrend


25% growth in investment 2002-03

70% growth in employment


74% growth in R&D manpower

US$ 5 billion annual revenues 2010 1 million skilled jobs 10% of global industry
March, 2005
Source: Confederation of Indian Industry (CII)

Biotechnology

India - An Overview
Market and Growth Potential Players Opportunities Why India? Contact in India
March, 2005

Indian Players

March, 2005

MNCs Scripting Success in India

March, 2005

Biotechnology

India - An Overview
Market and Growth Potential Players Opportunities Why India? Contact in India
March, 2005

Investments
Year
2000-01 2001-02 2002-03

US$ million 54 108.9 137.2

Growth (%) 102 26

Annual investments in this sector will be of the order of US$ 150


mn and are growing at the rate of 25%.

An additional investment of US$ 216 mn is expected in FY2005 March, 2005

Invest in Biopharmaceuticals

Vaccine

Sales of US$ 383.6 mn (2004-05)

Therapeutic

Marketing licenses granted for over 25 recombinant therapeutic proteins

Diagnostics Sales market - US$ 138.2 mn (2004-05)

March, 2005

India: The Vaccine Hub


Indian firms estimated to supply 90% of global demand for the measles vaccine, in the near future. Serum Institute, Pune is believed to be the world`s largest manufacturer of DPT vaccines.

Indian Immunologicals operates the world`s second largest plant for veterinary vaccines and is also the world`s largest manufacturer of the vaccine against Foot and Mouth Disease.
March, 2005

Invest in Biopharmaceuticals

Therapeutic

Accounts for 16.7% of total biopharma sales

Diagnostics

Forecast to grow by 35-40% in 2005 Immuno diagnostic market to increase 4 to 5 folds by 2005

March, 2005

Invest in Bioinformatics
By 2006 bionformatics market to grow 2004-05 By 2006 US$ 22.9 mn US$ 120 mn
Source: International Data Corporation (IDC)

Data mining Opportunities for Gene annotation Software bioinformatics interface development
March, 2005

investment

Invest in Genomics and Industrial Biotech

Genomics
Industrial Biotech
Size (2004-05)

US$ 73.5 mn

March, 2005

Invest in Agri Biotech

Biofertilisers

Biofuels

GM Crops and seeds

Biopesticides

March, 2005

Invest in Agri Biotech

Biofertilisers

Biofuels

GM Crops and seeds

Biopesticides

March, 2005

Clinical Trials - Destination India


Quality Speed Quality guidelines conformed Patient enrolment rates upto six times higher than US CROs to benefit from Indias IT

Technology
Disease Profile Investigators Genetic diversity Ethics
March, 2005

strengths in data management


High incidence of infectious/lifestyle diseases Excellent pool of qualified & trained doctors and physicians

Biotechnology

India - An Overview
Market and Growth Potential Players Opportunities Why India? Contact in India
March, 2005

The India Advantage

Excellent network of research laboratories

Well-developed base industries

Rich biodiversity

Extensive clinical trials opportunities

Trained manpower and knowledge base


March, 2005

The Infrastructure Advantage


40 National Research Institutes 300 life sciences colleges 15,000 scientists 500,000 graduates per annum 17,500 medical graduates per annum Employing 25,000 scientists in R&D Employing medical & paramedical professionals

120 medical colleges


200 biotech companies 100 teaching hospitals
March, 2005

The R & D Advantage


Genetic Engineering

Biotech R&D strengths spread across range of segments

DNA technologies
New Drug Delivery Systems

Rational drug design


Stem cell research Bioinformatics

March, 2005

The Policy Advantage


India has transitioned from a process patent regime to a product patent regime w.e.f January, 2005 150% weighted deduction on R&D expenditure Single window application processing proposed by DBT New biotech proposals to be cleared within 150 days Formation of a SME Growth Fund to provide equity support to small & medium units in the biotechnology sectors (Union BudgetMarch, 2005-06) 2005

Union Budget 2005-06


The Biotech Park Advantage Benefits enjoyed by Export Oriented Units (EOU) extended to Biotech Parks - 100% FDI permitted through automatic route - BTP units exempt from payment of Income Tax - Export proceeds to be realised within 12 months - BTPs allowed to retain 100% export earnings in the EEFC account
March, 2005

Biotechnology

India - An Overview
Market and Growth Potential Players Opportunities Why India? Contact in India
March, 2005

Contact in India
Confederation of Indian Industry (CII) The Mantosh Sodhi Centre 23 Institutional Area Lodi Road New Delhi 110003 Tel 0091 11 24629994 - 7 Fax 0091 11 24626149/24615693 E-mail c.banerjee@ciionline.org

March, 2005